Spotlight on Petrina Keating – MS Specialist Research Nurse
Being able to help people with multiple sclerosis (MS) and hopefully improve their day is something that inspires Perron Institute...
Continue reading
Latest news
Discover our latest videos on the Perron Institute YouTube channel. See the Perron Institute’s appearances in the media here.
WA researchers awarded funding to fuel future NHMRC success
A total of $4.73 million in funding has been awarded to 25 early and mid-career researchers under the Future Health...
Continue reading
Finding new biological markers for MS a focus for Dr Xiaonan Zhong MD PhD
Finding new biological markers for multiple sclerosis (MS) and other diseases remains a goal for Dr Xiaonan Zhong, MD and...
Continue reading
New funding to advance innovative multiple sclerosis research
WA researchers hope to gain new insights into the way immune cells in the body trigger attacks of multiple sclerosis...
Continue reading
WA researchers contribute to rare disease biomarker discovery
Recently published research on a rare autoimmune disorder that shares symptoms with multiple sclerosis (MS) has provided the first potential...
Continue reading
Potential treatment hope for Angelman syndrome supported by a Telethon grant
The initial development of a novel drug treatment for children living with rare genetic diseases including Angelman syndrome has been...
Continue reading
Spotlight on Ruby Shehatha – Clinical Research Assistant
From an early age, Ruby Shehatha knew she would work in the medical field. Her father is a surgeon and...
Continue reading
Learning about growing compassionate communities – a City of Stirling event
The significant role of communities in supporting people and their carers during illness and end of life is the theme...
Continue reading
Bone and brain focus continues for Dr Delin Liu
Dr Delin Liu is a recent PhD graduate in the Bone and Brain Axis Group at the Perron Institute and...
Continue reading
First stroke patient dosing with a WA-developed neuroprotective drug due to start soon
A Phase 2 clinical trial of the revolutionary neuroprotective drug ARG-007 is progressing well, towards a start in the first...
Continue reading
Tackling the global burden of stroke
An international Commission by The Lancet Neurology in collaboration with the World Stroke Organisation (WSO) and the World Health Organisation to understand...
Continue reading
MND research targets a new gene in hopes of a breakthrough
A new approach to enhance nerve fibre growth and promote nerve cell survival aims to buy precious time for people...
Continue reading